Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030092

Enrollment

Unknown

Registered

2020-02-23

Start date

2020-02-12

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Severe group:None

Critical group:none

Light group:None

Common group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosis confirmed Novel Coronavirus Pneumonia (COVID-19)

Exclusion criteria

Exclusion criteria: Diagnosis confirmed not coronavirus disease-19.

Design outcomes

Primary

Measure	Time frame
M mode echocardiography;two-dimensional echocardiography;Doppler ultrasound;two-dimensional speckle tracking;three-dimensional echocardiography;	—

Countries

China

Contacts

Public ContactMingxing Xie

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

xiemx@hust.edu.cn+86 13607108938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026